En vivo
Endpoints NewsAstellas touts data from early test of stem cell-derived eye therapy10x Genomics News10x Genomics (NASDAQ:TXG) Beats Q1 Estimates But Falls as Revenue Shrinks Year-Over-Year - ChartMill10x Genomics News10x Genomics: Q1 Earnings Snapshot - KTVB10x Genomics Blog10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops - StockStory10x Genomics Blog10x Genomics Reports First Quarter 2026 Financial Results - PR Newswire10x Genomics BlogQ1 2026: 10x Genomics (NASDAQ: TXG) narrows loss, launches Atera - Stock TitanBioPharma DiveSarepta tumbles as its gene therapy sales decline furtherClinical OMICsReduced Glaucoma Risk Connected to Migraine Medication UseScienceIn the remote Amazon, locals are saving a giant fish—and helping their villagesClinical OMICsBroader Immune Targeting Increases Immunotherapy Benefit in Colorectal CancerClinical OMICsAutism Screening Proposed for Children with EpilepsyClinical OMICsImmune Mapping Links Sex-Specific Genetics to Autoimmune Disease

Archivo

Reciente Más antiguo Borrar
@Agilent
Total 513
Fuente Agilent
Búsqueda --